United States · FDA National Drug Code directory
Excedrin Extra Strength Headache
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85237-1868_46fa8b27-fe58-4382-e063-6394a90a8965
- Product NDC
- 85237-1868
- Form
- TABLET, FILM COATED
- Composition / generic term
- Acetaminophen, Aspirin (NSAID), Caffeine
- Labeler
- Select Consumer Group
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20240101
- Source listing expiry
- 20261231
Source-listed ingredients
- ACETAMINOPHEN — 250 mg/1
- ASPIRIN — 250 mg/1
- CAFFEINE — 65 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 POUCH in 1 BLISTER PACK (85237-1868-1) / 2 TABLET, FILM COATED in 1 POUCH · 85237-1868-1
- 2 POUCH in 1 BLISTER PACK (85237-1868-2) / 2 TABLET, FILM COATED in 1 POUCH · 85237-1868-2
- 25 POUCH in 1 BOX, UNIT-DOSE (85237-1868-3) / 2 TABLET, FILM COATED in 1 POUCH · 85237-1868-3
- 50 POUCH in 1 BOX, UNIT-DOSE (85237-1868-6) / 2 TABLET, FILM COATED in 1 POUCH · 85237-1868-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →